News & Media
Health Kick Podcast: Filamon Co-Founder Professor Paul de Souza on Advancing Anti-Inflammatory Therapies for Cancer and Chronic Disease
Filamon CEO Dr Graham Kelly Updates JustStocks on the Upcoming ADVICE Clinical Trial for Cancer
Fierce Biotech
Australian biotech Filamon partners with Pi Health for anti-inflammatory cancer trial
Stockhead
Health Kick Podcast: Filamon Co-Founder Professor Paul de Souza on Advancing Anti-Inflammatory Therapies for Cancer and Chronic Disease
Just Stocks
Filamon CEO Dr Graham Kelly Updates JustStocks on the Upcoming ADVICE Clinical Trial for Cancer
JustStocks
Filamon CEO Tells JustStocks Its BETA-02 Eyedropper Aims to Revolutionise Wet AMD Treatment
JustStocks
Filamon CEO Dr Graham Kelly Discusses Upcoming Milestones For The Company’s Dementia Drug Candidate ALPHA-3
News Atlas
‘Breakthrough’ dementia drug looks to stop disease in its tracks
Retail Pharmacy
Biotech company announces potential dementia treatment breakthrough
JustStocks
Filamon CEO Discusses With JustStocks Video Potential Breakthrough In Dementia Treatment
JustStocks
Filamon CEO Dr Graham Kelly Speaks with Just Stocks about the Company’s technology platforms
Healthcare Channel
Breakthrough treatment offers hope for elderly blindness
Insight Ophthalmic News
Aussie biotech Filamon commercialising UNSW eye drop for AMD
Press Release